Acute profound thrombocytopenia after c7E3 Fab therapy.

Acute severe thrombocytopenia after treatment with ReoPro (abciximab). Heart (2000) 0.83

Acute profound thrombocytopenia after C7E3 Fab (abciximab) therapy. Circulation (1997) 2.55

The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 33.47

Replacement of the Bacillus subtilis subtilisin structural gene with an In vitro-derived deletion mutation. J Bacteriol (1984) 5.03

Characterization of the spo0A locus and its deduced product. Proc Natl Acad Sci U S A (1985) 4.86

Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site. Nat Struct Biol (1999) 4.37

The ECG in pulmonary embolism. Predictive value of negative T waves in precordial leads--80 case reports. Chest (1997) 4.29

Cloning, sequencing, and secretion of Bacillus amyloliquefaciens subtilisin in Bacillus subtilis. Nucleic Acids Res (1983) 3.70

Cloning of the neutral protease gene of Bacillus subtilis and the use of the cloned gene to create an in vitro-derived deletion mutation. J Bacteriol (1984) 3.41

Chromosomal location of a Bacillus subtilis DNA fragment uniquely transcribed by sigma-28-containing RNA polymerase. J Bacteriol (1982) 2.82

Cloning structural gene sacB, which codes for exoenzyme levansucrase of Bacillus subtilis: expression of the gene in Escherichia coli. J Bacteriol (1983) 2.73

Localization of Bacillus subtilis sacU(Hy) mutations to two linked genes with similarities to the conserved procaryotic family of two-component signalling systems. J Bacteriol (1988) 2.71

Studies of sigma D-dependent functions in Bacillus subtilis. J Bacteriol (1990) 2.53

Paternal concentrations of dioxin and sex ratio of offspring. Lancet (2000) 2.47

Isolation of Bacillus subtilis genes from a charon 4A library. J Bacteriol (1981) 2.45

Travel as a risk factor for venous thromboembolic disease: a case-control study. Chest (1999) 2.34

Identification of the pleiotropic sacQ gene of Bacillus subtilis. J Bacteriol (1986) 2.33

Effect of stage 0 sporulation mutations on subtilisin expression. J Bacteriol (1986) 2.31

De novo initiation of RNA synthesis by hepatitis C virus nonstructural protein 5B polymerase. J Virol (2000) 2.19

Biochemical and functional comparison of DNA polymerases alpha, delta, and epsilon from calf thymus. J Biol Chem (1991) 2.08

Generation of large libraries of random mutants in Bacillus subtilis by PCR-based plasmid multimerization. Biotechniques (1997) 2.01

A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire. N Engl J Med (1997) 1.97

Location of the targets of the hpr-97, sacU32(Hy), and sacQ36(Hy) mutations in upstream regions of the subtilisin promoter. J Bacteriol (1988) 1.74

Cloning and localization of the lepidopteran protoxin gene of Bacillus thuringiensis subsp. kurstaki. Proc Natl Acad Sci U S A (1982) 1.71

Effect of paraoxonase-1 polymorphism on clinical outcomes in patients treated with clopidogrel after an acute myocardial infarction. Clin Pharmacol Ther (2011) 1.67

Template/primer requirements and single nucleotide incorporation by hepatitis C virus nonstructural protein 5B polymerase. J Virol (2000) 1.63

Characterization of the levanase gene of Bacillus subtilis which shows homology to yeast invertase. Mol Gen Genet (1987) 1.58

Impact of attenuation correction by simultaneous emission/transmission tomography on visual assessment of 201Tl myocardial perfusion images. J Nucl Med (1999) 1.57

Characterization and mapping of the Bacillus subtilis prtR gene. J Bacteriol (1987) 1.55

Box C/D small nucleolar RNA trafficking involves small nucleolar RNP proteins, nucleolar factors and a novel nuclear domain. EMBO J (2001) 1.47

Structure, function and assembly of the nucleolus. Trends Cell Biol (1993) 1.41

[Precaution in the thrombolytic treatment of myocardial infarction]. Presse Med (1989) 1.40

Six French sheathless coronary angioplasty using a novel technique to introduce the guiding catheter: the INTRUC, a preliminary retrospective study. Cathet Cardiovasc Diagn (1998) 1.39

[Severe early pulmonary embolism after blockage of the vena cava]. Presse Med (1994) 1.39

Intrapericardial bronchogenic cyst: an unusual cause of CA 19-9 increase. Eur J Med (1992) 1.39

[Duration of antivitamin K therapy in venous thromboembolic disease]. Arch Mal Coeur Vaiss (1995) 1.38

Enzymatic characterization of hepatitis C virus NS3/4A complexes expressed in mammalian cells by using the herpes simplex virus amplicon system. J Virol (1996) 1.38

Mutational analysis of bovine viral diarrhea virus RNA-dependent RNA polymerase. J Virol (1999) 1.37

Cloning and expression in Escherichia coli of three lipase-encoding genes from the psychrotrophic antarctic strain Moraxella TA144. Gene (1991) 1.33

p38alpha blockade inhibits colorectal cancer growth in vivo by inducing a switch from HIF1alpha- to FoxO-dependent transcription. Cell Death Differ (2009) 1.30

Correlation between Bacillus subtilis scoC phenotype and gene expression determined using microarrays for transcriptome analysis. J Bacteriol (2001) 1.26

Molecular cloning of the spo0B sporulation locus in bacteriophage lambda. J Bacteriol (1982) 1.23

The X-ray structure of a recombinant major urinary protein at 1.75 A resolution. A comparative study of X-ray and NMR-derived structures. Acta Crystallogr D Biol Crystallogr (2001) 1.20

Nucleotide sequence of the lipase gene lip2 from the antarctic psychrotroph Moraxella TA144 and site-specific mutagenesis of the conserved serine and histidine residues. DNA Cell Biol (1991) 1.20

Seasonal variation in chronic heart failure hospitalizations and mortality in France. Circulation (1999) 1.19

SCH 48973: a potent, broad-spectrum, antienterovirus compound. Antimicrob Agents Chemother (1997) 1.17

Genetic and enzymic studies on the recombination process in Bacillus subtilis. Mol Gen Genet (1975) 1.16

[Treatment of primary cardiogenic shock by coronary transluminal angioplasty during the acute phase of myocardial infarction]. Arch Mal Coeur Vaiss (1990) 1.14

Four different DNA helicases from calf thymus. J Biol Chem (1992) 1.10

Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice. Cancer Res (1998) 1.10

Atherosclerosis of the thoracic aorta and aortic debris as a marker of poor prognosis: benefit of oral anticoagulants. J Am Coll Cardiol (1999) 1.10

The role of endosome destabilizing activity in the gene transfer process mediated by cationic lipids. FEBS Lett (1997) 1.09

Electron tomography of metaphase nucleolar organizer regions: evidence for a twisted-loop organization. Mol Biol Cell (1997) 1.08

Genetic contribution to idiopathic adult-onset blepharospasm and cranial-cervical dystonia. Eur Neurol (1993) 1.07

Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial. Pediatrics (2001) 1.06

Resistance of human nucleotide excision repair synthesis in vitro to p21Cdn1. Oncogene (1998) 1.06

Indocyanine green angiography in central serous chorioretinopathy. ICG angiography in CSC. Int Ophthalmol (1997) 1.04

Thyroid function in physiological aging and in centenarians: possible relationships with some nutritional markers. Metabolism (2002) 1.04

Nucleotide sequence of the outB locus of Bacillus subtilis and regulation of its expression. J Bacteriol (1987) 1.03

Studies on transduction process by SPP1 phage. J Gen Virol (1978) 1.03

Calf thymus DNA polymerase delta independent of proliferating cell nuclear antigen (PCNA). Nucleic Acids Res (1989) 1.03

Effects of different types of exercise training followed by detraining on endothelium-dependent dilation in patients with recent myocardial infarction. Circulation (2009) 1.01

Do DNA polymerases delta and alpha act coordinately as leading and lagging strand replicases? FEBS Lett (1988) 1.01

DNA polymerase switching: II. Replication factor C abrogates primer synthesis by DNA polymerase alpha at a critical length. J Mol Biol (2000) 0.99

Reactivity of autoantibodies in systemic lupus erythematosus with synthetic core histone peptides. Int Arch Allergy Appl Immunol (1989) 0.97

Effects of diet-therapy on urinary protein excretion albuminuria and renal haemodynamic function in obese diabetic patients with overt nephropathy. Int J Obes (1989) 0.97

[Guidelines for good clinical practice: prevention and treatment of venous thromboembolism in medical patients]. J Mal Vasc (2010) 0.96

Solution structure of a recombinant mouse major urinary protein. Eur J Biochem (1999) 0.95

Changes of serum allopregnanolone levels in the first 2 years of life and during pubertal development. Pediatr Res (1999) 0.95

The p15 carboxyl-terminal proteolysis product of the human immunodeficiency virus type 1 reverse transcriptase p66 has DNA polymerase activity. Proc Natl Acad Sci U S A (1991) 0.94

Clinical epidemiology of venous thromboembolic disease. Results of a French Multicentre Registry. Eur Heart J (1997) 0.94

Behaviour of nucleolus during mitosis. A comparative ultrastructural study of various cancerous cell lines using the Ag-NOR staining procedure. Chromosoma (1987) 0.93

Sequence of a lipase gene from the antarctic psychrotroph Moraxella TA144. Nucleic Acids Res (1990) 0.93

Novel splice isoforms of STRADalpha differentially affect LKB1 activity, complex assembly and subcellular localization. Cancer Biol Ther (2007) 0.93

Ultrastructural cytochemistry of the mammalian cell nucleolus. J Histochem Cytochem (1990) 0.92

Menstrual cycle and ovary alterations in women with epilepsy on antiepileptic therapy. J Endocrinol Invest (1997) 0.92

Needle aspiration techniques in preoperative selection of patients with thyroid nodules: a long-term study. J Clin Oncol (1996) 0.92

Sheehan's syndrome with complete bone marrow aplasia: long-term results of substitution therapy with hormones. Br J Haematol (1976) 0.92

Overproduction of IFN-gamma and TNF-alpha from natural killer (NK) cells is associated with abnormal NK reactivity and cognitive derangement in Alzheimer's disease. Ann N Y Acad Sci (2000) 0.91

Prevalence of toxoplasma myocarditis in patients with the acquired immunodeficiency syndrome. Br Heart J (1993) 0.91

Neutrophils as mediators of human skeletal muscle ischemia-reperfusion syndrome. Hum Pathol (1992) 0.91

RNA-dependent RNA polymerase activity encoded by GB virus-B non-structural protein 5B. J Viral Hepat (2000) 0.91

Two-colour pump-probe experiments with a twin-pulse-seed extreme ultraviolet free-electron laser. Nat Commun (2013) 0.90

Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma. Oncogene (2012) 0.90

Circadian secretory pattern of growth hormone, insulin-like growth factor type I, cortisol, adrenocorticotropic hormone, thyroid-stimulating hormone, and prolactin during HIV infection. AIDS Res Hum Retroviruses (1997) 0.90

Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix. J Clin Oncol (1999) 0.89

Changes in endocrine circadian rhythms as markers of physiological and pathological brain aging. Chronobiol Int (1997) 0.89

PAF67, a novel protein that is associated with the initiation-competent form of RNA polymerase I. Biol Chem (2001) 0.89

Light panretinal photocoagulation (LPRP) versus classic panretinal photocoagulation (CPRP) in proliferative diabetic retinopathy. Semin Ophthalmol (2001) 0.89

Lymphoma developing in a patient with rheumatoid arthritis taking methotrexate. Clin Rheumatol (1993) 0.88

Isolated so-called apraxia of eyelid opening: report of 10 cases and a review of the literature. Eur Neurol (1998) 0.88

Engineering of quorum-sensing systems for improved production of alkaline protease by Bacillus subtilis. J Appl Microbiol (2004) 0.88

Regulation of DNA metabolic enzymes upon induction of preB cell development and V(D)J recombination: up-regulation of DNA polymerase delta. Nucleic Acids Res (1997) 0.87

HDAC5 is required for maintenance of pericentric heterochromatin, and controls cell-cycle progression and survival of human cancer cells. Cell Death Differ (2012) 0.87

A novel member of the subtilisin-like protease family from Bacillus subtilis. Microbiology (1999) 0.87

Interatrial conduction in patients undergoing AV stimulation: effects of increasing right atrial stimulation rate. Pacing Clin Electrophysiol (1993) 0.87

Phase I study with weekly cisplatin-paclitaxel and concurrent radiotherapy in patients with carcinoma of the cervix uteri. Ann Oncol (2000) 0.86

Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes. Ital J Neurol Sci (1999) 0.86